Previous Article | Next Article 
Molecular and Cellular Biology, July 2001, p. 4553-4567, Vol. 21, No. 14
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.14.4553-4567.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Redistribution of Glycolipid Raft Domain Components
Induces Insulin-Mimetic Signaling in Rat Adipocytes
Günter
Müller,*
Christian
Jung,
Susanne
Wied,
Stefan
Welte,
Holger
Jordan, and
Wendelin
Frick
Aventis Pharma Germany, 65926 Frankfurt am
Main, Germany
Received 8 November 2000/Returned for modification 8 February
2001/Accepted 15 April 2001
 |
ABSTRACT |
Caveolae and caveolin-containing detergent-insoluble
glycolipid-enriched rafts (DIG) have been implicated to
function as plasma membrane microcompartments or domains for the
preassembly of signaling complexes, keeping them in the basal inactive
state. So far, only limited in vivo evidence is available for the
regulation of the interaction between caveolae-DIG and signaling
components in response to extracellular stimuli. Here, we demonstrate
that in isolated rat adipocytes, synthetic intracellular caveolin
binding domain (CBD) peptide derived from caveolin-associated
pp59Lyn (10 to 100 µM) or exogenous phosphoinositolglycan
derived from glycosyl-phosphatidylinositol (GPI) membrane protein
anchor (PIG; 1 to 10 µM) triggers the concentration-dependent release
of caveolar components and the GPI-anchored protein Gce1, as well as
the nonreceptor tyrosine kinases pp59Lyn and
pp125Fak, from interaction with caveolin (up to 45 to
85%). This dissociation, which parallels redistribution of the
components from DIG to non-DIG areas of the adipocyte plasma membrane
(up to 30 to 75%), is accompanied by tyrosine phosphorylation and
activation of pp59Lyn and pp125Fak (up to 8- and 11-fold) but not of the insulin receptor. This correlates well to
increased tyrosine phosphorylation of caveolin and the insulin receptor
substrate protein 1 (up to 6- and 15-fold), as well as elevated
phosphatidylinositol-3' kinase activity and glucose transport (to up to
7- and 13-fold). Insulin-mimetic signaling by both CBD peptide and PIG
as well as redistribution induced by CBD peptide, but not by PIG, was
blocked by synthetic intracellular caveolin scaffolding domain (CSD)
peptide. These data suggest that in adipocytes a subset of signaling
components is concentrated at caveolae-DIG via the interaction between
their CBD and the CSD of caveolin. These inhibitory interactions are
relieved by PIG. Thus, caveolae-DIG may operate as signalosomes for
insulin-independent positive cross talk to metabolic insulin signaling
downstream of the insulin receptor based on redistribution and
accompanying activation of nonreceptor tyrosine kinases.
 |
INTRODUCTION |
Caveolae, caveolin-containing
small invaginations of the plasma membrane expressed in many
differentiated cells (2, 50, 51, 54), and their
biochemical correlate, detergent-insoluble glycolipid-enriched raft
domains (DIG) (5, 53), harbor a number of components
of various intracellular signal transduction pathways, including G
protein-coupled receptors, heterotrimeric and small G proteins,
nonreceptor tyrosine kinases (NRTK), components of the
Ras/mitogen-activated protein kinase (MAPK) pathway, protein kinase C
isoforms, endothelial nitric oxide synthase (eNOS), and glycosyl-phosphatidylinositol-anchored plasma membrane proteins (GPI
proteins; 2, 55, 58, 59, 60). As a consequence, these
structures may function as sites for direct physical interaction of
signaling components where (positive or negative) cross talk between
the corresponding signaling pathways takes place (49). A
large body of evidence strongly suggests that caveolin family members
(caveolins 1, 2, and 3 and flotillins) (3, 21) operate as
scaffolding proteins which organize and concentrate cholesterol and
glycosphingolipids as well as lipid-modified signaling proteins within caveolae-DIG, thereby suppressing their activity via
direct interaction with caveolin (31, 32, 61). Recently,
it was demonstrated that caveolin 1 functionally suppresses
the GTPase activity of heterotrimeric G proteins and
blocks the activity of eNOS as well as (receptor and nonreceptor)
tyrosine kinases by direct binding of a common domain within the
caveolins, the caveolin scaffolding domain (CSD) to the corresponding
caveolin binding domain (CBD) of the signaling protein (10, 27,
48). Functional CBDs have also been identified in
serine/threonine kinases (51), where they are located
within the conserved kinase subdomain IX. Taken together, this
argues for caveolin operating as a general kinase inhibitor
(11). Compatible with this hypothesis is the finding that
synthetic CSD peptide (CSDP) inhibits Src family tyrosine kinases
(c-Src/Fyn), epidermal growth factor receptor, MAPK, G
protein-coupled receptor kinases, and protein kinases C and A, with
similar potencies in vitro (7, 11, 14, 31, 48, 51).
However, in contrast to the large body of in vitro evidence for the
so-called caveola signaling hypothesis (34), there is only
limited demonstration for functional relevance of the CBD-CSD
interaction in vivo. Inactivation of the CBD of eNOS by site-directed
mutagenesis (within the FSAAPFSGW
motif; italics indicate invariant amino acids of the CBD consensus
sequence) (see Fig. 1) led to the blockade of the ability of caveolin 1 to inhibit eNOS activity, thus indicating functional relevance of
caveolin binding to a signaling protein in vivo (20).
If relevant in vivo, the inhibitory interaction between caveolin
and signaling molecules should be accessible for modulation in response
to extracellular and intracellular signals. Activation of signaling
pathways engaging CBD-harboring components requires their relief
from binding to or inhibition by caveolin. The molecular mechanism for
long-term response may be based on the regulation of caveolin gene
expression. Consistent with this hypothesis, caveolin 1 mRNA and
protein expression as well as the number of caveolae are dramatically
diminished upon cell transformation by activated oncogenes, such
as H-Ras (28). In these transformed cells, ectopic
caveolin 1 expression and concomitant formation of caveolae
prevented the transformed phenotype, accompanied by downregulation of the MAPK pathway (15). Conversely,
antisense-mediated reduction in caveolin 1, but not caveolin 2, expression in NIH 3T3 cells led to oncogenic transformation and
constitutive activation of the MAPK cascade (19).
Interestingly, caveolins 1 and 2 are coexpressed and form
heterooligomeric DIG via their membrane-spanning domains in most cell
types (12, 56). Thus, in addition to the absolute caveolin
1 level, the stoichiometry of caveolins 1 and 2 protein expression
could affect the inhibitory potency by the masking of CSD of caveolin 1 by CSD of caveolin 2 within the assembled heterooligomeric
caveolae-DIG.
Here, we demonstrate that in isolated rat adipocytes, two NRTK are
downregulated by localization in DIG and by binding to caveolin and
upregulated by release from DIG and by dissocation from caveolin in
response to phosphoinositolglycans (PIG), cleavage products of GPI
protein anchors (18, 26, 41). Short-term redistribution of
these NRTKs from caveolae-DIG induces potent insulin-independent
activation of metabolic insulin signaling.
 |
MATERIALS AND METHODS |
Materials.
Radiochemicals and chemiluminescent reagents
(Renaissance Chemiluminescence Detection System) were bought from
NEN/DuPont (Bad Homburg, Germany); PIG 41, 37, 7, and 1 (18) were made available by Jochen Bauer and Andrea Bauer
(Department of Medicinal Chemistry of Aventis Pharma, Frankfurt am
Main, Germany); and antibodies were obtained as follows. For
immunoprecipitation, antibodies against pp59Lyn
(clone 42), pp125Fak (clone 77), and caveolin 1 (rabbit) were from Transduction Laboratories (Lexington, Ky.);
antibodies against total human recombinant (insect cells; purified by
gel filtration) insulin receptor substrate protein 1 (IRS-1) and IRS-2
(rabbit) were from Biotrend (Cologne, Germany); and antibodies against
human insulin receptor
-subunit (IR
; monoclonal) were from
Upstate Biotechnology (Lake Placid, N.Y.). For immunoblotting,
antibodies against phosphotyrosine (clone PY20) were from Transduction
Laboratories; those against phosphotyrosine (clone 4G10) were from
Upstate Biotechnology; those against synthetic peptide corresponding to
the carboxy-terminal sequence comprising amino acids 1223 to 1235 of
rat IRS-1 (rabbit) were from Suzanne Dalle (Humbold University, Berlin,
Germany); antibodies against paxillin (clone 165), caveolin
(rabbit), pp59Lyn (clone 32), and
pp125Fak (clone 197) were from Transduction
Laboratories; those against human integrin
1
and IR
were from Upstate Biotechnology; and those against rat
glucose transporter isoform 1 (Glut1) and Glut4 (rabbit) were from
Biotrend. Rabbit muscle enolase, 1-methyl-2-phenylethyladenosine, fatty-acid-free bovine serum albumin (BSA; fraction V) and
N-ethylmaleimide were purchased from Sigma (Deisenhofen,
Germany); protein A- and G-Sepharose were delivered by Pharmacia/Upjohn
(Freiburg, Germany); proteinase inhibitors and adenosine deaminase were
from Roche Molecular Biochemicals (Mannheim, Germany); precast gels
were purchased from Novex (San Diego, Calif.); and polyvinylidene
difluoride membranes were obtained from Millipore, Eschborn, Germany.
Synthesis of peptides.
The wild-type and mutant CBD peptides
(CBDP) derived from pp59Lyn as well as CSDP (Fig.
1) were synthesized on an Applied
Biosystems Model 431A Peptide Sequencer by using 9-fluorenylmethoxy
carbonyl as the
-amino protecting group. Coupling of amino acids to
the nascent peptide was carried out in N-methylpyrrolidone
using HOBT-HBTU [N-hydroxybenzotriazole-2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate].
9-Fluorenylmethoxy carbonyl was removed by treatment of the peptide
with 15% piperidine in N-methylpyrrolidone. Cleavage of the
peptide from the resin and deprotection of amino acid chains was
carried out by reaction with 95% trifluoroacetic acid (3 h, room
temperature) in water containing phenol, ethanedithiol, and thioanisole
as scavengers. Peptide was removed from resin by filtration and
precipitated in diethyl ether. Peptides were purified by reversed-phase
high-performance liquid chromatography, and their molecular weights
were confirmed by mass spectroscopy.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
Structural and functional organization of caveolin 1
and the amino acid sequences of the wild-type or mutant CSDP derived
from caveolin 1 , 2, and 3 as well as CBDP derived from
pp59Lyn. The CBD consensus sequence for functional
interaction of signaling proteins with caveolin is also given.
Palmitoylation at the carboxy-terminal domain of caveolin 1 is
thought to support caveolar assembly (56, 60).
|
|
Preparation of rat adipocytes and incubation with PIG.
Adipocytes were isolated by collagenase digestion from epididymal fat
pads of male Wistar rats (140 to 160 g, fed ad libitum) as
described previously (40). At a final concentration of 100 µl of packed cell volume per ml (determined by aspiration of small aliquots into capillary hematocrit tubes and centrifugation for 90 s in a microhematocrit centrifuge in order to measure the fractional occupation of the suspension by the adipocytes; 10% cytocrit
corresponds to about 1.5 × 106 cells/ml),
cells were incubated in HEPES-based Krebs-Ringer solution (KRH; 0.12 M
NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM
MgSO4, 1.2 mM
KH2PO4, 20 mM HEPES-KOH, pH
7.4) containing 2% (wt/vol) BSA, 100 µg of gentamicin/ml, 100 nM
1-methyl-2-phenylethyladenosine, 0.5 U of adenosine deaminase/ml, 0.5 mM sodium pyruvate, and 5 mM D-glucose in the presence of
PIG (dissolved in 20 mM HEPES-KOH, pH 7.4) at 37°C in a shaking water
bath with constant bubbling with 5% CO2-95%
O2 for the periods indicated.
Electroporation of isolated rat adipocytes
Electroporation was performed as described previously (44)
by incubating (at 25°C) the adipocytes (25% cytocrit) in a cuvette in 0.8 ml of 4.74 mM NaCl, 118 mM KCl, 0.38 mM CaCl2, 1 mM
EGTA, 1.19 mM MgSO4, 1.19 mM
KH2PO4, 25 mg of BSA/ml, 3 mM sodium pyruvate, and 25 mM HEPES-KOH (pH 7.4) in the presence of CBDP-CSDP (dissolved in
dimethyl sulfoxide at 30 mM; final dimethyl sulfoxide concentration of
1%, which was also contained in control incubations and did not affect
adipocyte viability) at the concentrations indicated and using a Gene
Pulser Transfection Apparatus (Bio-Rad, Munich, Germany; set at a
capacitance of 25 µF and voltage of 2 kV/cm) for six shocks. The
cells from five electroporations were pooled and centrifuged (200 × g, 1 min, swing-out rotor). After aspiration of the
infranatant, the cells were washed once with 40 ml of the above buffer
containing 4% BSA, suspended in 20 ml of Dulbecco's minimal essential
medium containing 5 mM glucose, 0.5 M mM sodium pyruvate, 4 mM
L-glutamine, 200 nM 1-methyl-2-phenylethyladenosine, 100 µg of gentamicin/ml, 1% BSA, and 25 mM HEPES-KOH (pH 7.4), and then
incubated (1 h, 37°C) under 5% CO2-95% O2
prior to stimulation with PIG.
Preparation of total-cell lysate and plasma membranes.
After
stimulation and/or electroporation, rat adipocytes (5 × 107 cells) were washed once with KRH containing
0.25 M sucrose and 2 mM sodium pyruvate by flotation (200 × g, 2 min) and aspiration of the infranatant and were
immediately homogenized in 10 ml of lysis buffer (25 mM Tris-HCl, pH
7.4, 0.5 mM EDTA, 0.25 mM EGTA, 0.25 M sucrose, 50 mM NaF, 5 mM sodium
pyrophosphate, 25 mM glycerol-3-phosphate, and 1 mM sodium
orthovanadate, supplemented with protease inhibitors [10 µg of
leupeptin/ml, 2 µM pepstatin, 10 µg of aprotinin/ml, 5 µM
antipain, 5 mM iodoacetate, 100 µM phenylmethylsulfonyl fluoride, 4 mM benzamidine]) by using a motor-driven Teflon-in-glass homogenizer (10 strokes with a loosely fitting pestle) at 22°C. The following procedures were performed at 4°C (43). After
centrifugation (1,500 × g, 5 min), the postnuclear
infranatant was separated from the fat cake, and the pellet fraction
(containing adipocyte ghosts and cell debris) was removed by suction
with a needle. For preparation of plasma membranes, the postnuclear
infranatant was centrifuged (12,000 × g, 15 min). The
pellet was suspended in 10 ml of homogenization buffer and
recentrifuged (1,000 × g, 10 min). The supernatant was
centrifuged (12,000 × g, 20 min). The washed pellet
was suspended in 1 ml of homogenization buffer, layered onto a 5-ml
cushion of 38% (wt/vol) sucrose, 25 mM Tris-HCl (pH 7.4), and 1 mM EDTA, and centrifuged (110,000 × g, 1 h). The membranes at the interface between the two layers (0.5 ml) were removed
by suction, diluted with four volumes of homogenization buffer, and
layered on top of an 8-ml cushion of 28% Percoll, 0.25 M sucrose, 1 mM
EDTA, and 25 mM Tris-HCl (pH 7.0). After centrifugation (45,000 × g, 30 min), the plasma membranes were withdrawn from the
lower third of the gradient (0.5 ml) with a Pasteur pipette, diluted
with 10 volumes of homogenization buffer, and centrifuged (200,000 × g, 90 min). The washed pellet was suspended in the same
buffer at 0.5 mg of protein/ml. For solubilization of plasma membranes
and preparation of total-cell lysate, plasma membranes and postnuclear
infranatant, respectively, were supplemented with deoxycholate and
Nonidet P-40 (final concentrations, 0.3 and 0.2%, respectively), and
after incubation (1 h, 4°C), the solubilized plasma membranes and
total-cell lysates were cleared from insoluble material by
centrifugation (100,000 × g, 1 h, 4°C) and used
for photoaffinity labeling and (co)immunoprecipitation.
Preparation of DIG. (i) Detergent method.
Washed adipocytes
(3.5 × 106) were suspended in 1.5 ml of
lysis buffer (25 mM morpholinoethanesulfonic acid [MES], pH 6.0, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.2 mM sodium
orthovanadate, and protease inhibitors) and incubated for 20 min on
ice. The cells were lysed with 10 strokes in a manual Teflon-in-glass
homogenizer over the course of 1 h at 4°C. The lysate was
centrifuged (1,300 × g, 5 min) to pellet unbroken
cells, cellular debris, nuclei, and large insoluble material. A 1-ml
volume of the postnuclear supernatant was subjected to sucrose gradient
centrifugation by mixing with an equal volume of 85% sucrose,
25 mM MES (pH 6.0), 150 mM NaCl, and 5 mM EDTA at the bottom of a 12-ml
centrifuge tube which was overlaid with 5.5 ml of 35% sucrose and then
3.5 ml of 5% sucrose in the same medium. After centrifugation
(230,000 × g, Beckman SW41 rotor, 18 h, 4°C),
0.9-ml fractions were collected from top to bottom and termed fractions
1, 2, 3, etc. The bottom fraction was fraction 12. Fraction 5 appeared
as a white, light-scattering band under illumination located at 5 to
7% sucrose at the 35% sucrose interface. DIG contained in fraction 5 were pelleted by dilution of the sucrose with 5 volumes of 50 mM
HEPES-KOH containing protease inhibitors and centrifugation
(200,000 × g, 2 h).
(ii) Carbonate method.
Plasma membranes (200 µg) were
pelleted (200,000 × g, 90 min), suspended in 1.5 ml of
0.5 M Na2CO3 (pH 11)
containing protease inhibitors, and sonicated (three 30-s bursts with
1-min intervals on ice; Branson B-12, power stage 4). The suspension
was then adjusted to 45% sucrose in a medium containing 15 mM MES-KOH
(pH 6.5), 75 mM NaCl, and 0.25 M
Na2CO3 overlaid with 2 ml
each of 35, 25, 15, and 5% sucrose in the same medium and was
centrifuged (230,000 × g, Beckman SW41 rotor, 18 h). The light-scattering band of flocculent material just below the 15 to 25% sucrose interface was collected as DIG using a 19-gauge needle
and a syringe (about 1.5 ml). Alternatively, washed adipocytes
(0.5 × 107 cells) were suspended in 2 ml of
sodium carbonate buffer and homogenized sequentially using a loosely
fitting Dounce homogenizer (10 strokes) and a sonicator (three 20-s
bursts). The homogenate (2 ml) was then adjusted to 45% sucrose by
addition of 2 ml of 90% sucrose, 50 mM MES-KOH (pH 6.5), and 150 mM
NaCl (final pH of the mixture, 10.2). A discontinuous sucrose
gradient was formed by overlaying this solution with 4 ml of 35%
sucrose and 4 ml of 5% sucrose, both in the same buffer containing
0.25 M Na2CO3. After
centrifugation (see above), 0.85-ml gradient fractions were collected
to yield a total of 14 fractions. The individual gradient fractions
were pooled into DIG (fractions 4 to 7) and non-DIG areas (fractions 10 to 14). The membranes from each of the pooled gradient fractions
obtained by either method were diluted two- to threefold with 25 mM MES
(pH 6.5), 150 mM NaCl, and 1% Triton X-100, collected by
centrifugation (50,000 × g, 30 min, 4°C), resuspended in nondissociating buffer (10 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 1% Nonidet P-40, 5 mM EDTA, 0.5 mM EGTA, 1 mM sodium orthovanadate, 50 mM NaF, and protease inhibitors) or dissociating buffer (composed of nondissociating buffer supplemented with 60 mM
-octylthioglucoside, 0.3% deoxycholate) as indicated, incubated (1 h, on ice), and used for (co)immunoprecipitation, immunoblotting, or
photoaffinity labeling.
Immune complex kinase assays
Immune complex
kinase assays were performed as described previously (17,
44) with minor modifications. Briefly, pp59Lyn or
pp125Fak immune complexes were suspended in 30 µl of
kinase buffer (50 mM HEPES-KOH, pH 7.4, 100 mM NaCl, 1.25 mM
MnCl2, 12.5 mM MgCl2, 1.25 mM EGTA, 0.5 mM
dithiothreitol, 1 mM Na3VO4) containing
[
-32P]ATP (final concentrations: pp59Lyn,
40 µM, 0.2 mCi/ml; pp125Fak, 100 µM, 0.5 mCi/ml) or 1 mM ATP and were incubated (pp59Lyn, 15 min;
pp125Fak, 3 min; 22°C) in the presence of 1 µg of
heat-denatured enolase. Phosphorylation was terminated by addition of
10 µl of fourfold-concentrated Laemmli buffer and boiling. The
phosphoproteins were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (10% Bis-Tris resolving gel,
morpholinopropanesulfonic acid [MOPS]-SDS running buffer) and
analyzed for phosphotyrosine by phosphorimaging ([
-32P]ATP) or immunoblotting (ATP). Under these
conditions, the kinase reactions were linear with time for the assay period.
Miscellaneous
Phosphatidylinositol 3'-kinase
(PI-3'K) assay, photoaffinity labeling of Gce1 with
8-N3-[32P]cyclic AMP (cAMP),
immunoprecipitation, and immunoblotting were performed as described
previously (17, 39, 43, 44). Protein concentration
was determined using the bicinchoninic acid protein determination kit
from Pierce (Rockford, Ill.) and BSA as a calibration standard.
Autoradiographs and direct photoimages were processed and quantified by
computer-assisted video densitometry using the Storm 860 PhosphorImager
system (Molecular Dynamics, Gelsenkirchen, Germany). Figures of
autoradiographs and photoimages were constructed using the Adobe
Photoshop software (Adobe Systems Inc., Mountain View, Calif.). The
recovery in the amount of immunoprecipitated protein was corrected (by
fold increase or percent stimulation) for the amount of protein
actually applied onto the gel as revealed by homologous immunoblotting.
Each experiment and incubation was performed with different batches of
adipocytes (see figure legends), with two to four independent
immunoprecipitation, kinase assay, immunoblotting, or photoaffinity
labeling analyses.
 |
RESULTS |
Characterization of DIG in rat adipocytes.
DIG are assumed to
represent the biochemical correlate for (certain subsets of) the
morphologically defined caveolae and/or precaveolae prior to their
invagination or budding from the plasma membrane (49, 60).
The protein composition of DIG and non-DIG areas prepared by the
carbonate method from purified plasma membranes or by the detergent
method from total-cell lysates of untreated isolated rat adipocytes was
analyzed by immunoblotting. The caveolar structural and marker protein,
caveolin 1, the GPI proteins Gce1 (glycolipid-anchored cAMP-binding
ectoprotein) and 5'-nucleotidase (39, 43, 46), and the
dual-acylated NRTK of the Src-class, pp59Lyn
(52), were significantly enriched with DIG (versus total
plasma membranes) prepared by either method (Table
1). The typical plasma membrane proteins,
glucose transporter isoforms Glut1 and Glut4, IR
, and
Na+/K+-ATPase were deprived
from DIG areas (versus plasma membranes) and recovered mainly from
non-DIG areas. Previous studies provided controversial data about the
presence of Glut4 and the insulin receptor in caveolae-DIG from 3T3-L1
and rat adipocytes (24, 57). Furthermore, the present
study revealed deprivement of Golgi-derived vesicles and
clathrin-coated pits from both DIG and non-DIG areas based on their low
content of COPII vesicle protein
and clathrin
-chain,
respectively, relative to total plasma membranes (Table 1). Thus,
cytoskeletal components, which are characterized by detergent
insolubility, did not contaminate the DIG prepared by both methods to
any significant degree. Based on the comparable enrichment and
deprivement factors, DIG areas (and non-DIG areas) of qualitatively
similar protein composition can be prepared by the carbonate and
detergent methods.
After dissociation of the DIG (detergent method) with octylglucoside
plus deoxycholate (see Materials and Methods), 65 to
85% of
pp59
Lyn and pp125
Fak
present in DIG from basal adipocytes (as detected by immunoblotting
of
1% SDS-solubilized DIG) was immunoprecipitated with caveolin
1. In contrast, less than 5% of Gce1 present in SDS-solubilized
DIG
was recovered with caveolin 1 immunoprecipitates from octylglucoside
plus deoxycholate-dissociated DIG. This suggests a direct interaction
between pp59
Lyn-pp125
Fak
and caveolin 1 within caveolae-DIG which resists their dissociation
by
octylglucoside plus deoxycholate to a considerable degree but
is
disrupted by 60 mM octylglucoside plus 1% Nonidet P-40 (5 to
8%
coimmunoprecipitation) or by 1% SDS (0.5 to 1%
coimmunoprecipitation).
In contrast, the localization of GPI proteins,
such as Gce1, in
caveolae-DIG apparently does not rely on direct
binding to caveolin
1 but requires the intact structural organization
of caveolae-DIG
(in the presence of 1% Nonidet P-40 only). Thus,
caveolin 1 (co)immunoprecipitates
from nondissociated DIG harbor
caveolar-DIG components irrespective
of the molecular mechanism of
their retention. Caveolin 1 immunoprecipitates
from dissociated DIG
recover only caveolin-interacting caveolar-DIG
components. The
conditions used for both immunoprecipitations
result in efficient
removal of noncaveolar plasma membrane
polypeptides.
CBDP and PIG abrogate caveolin-pp59Lyn interaction and
stimulate pp59Lyn and insulin-mimetic signaling.
For
demonstration of functional interaction between caveolin and NRTKs in
DIG of the adipocyte plasma membrane, possibly mediated by the CSD and
CBD, respectively (see Introduction), an excess of synthetic CBDP
derived from pp59Lyn (Fig. 1) (41,
49) was introduced into isolated rat adipocytes by
electroporation and analyzed for the effect on the association between
caveolin and pp59Lyn residing in DIG (Fig.
2). The wild-type but not the mutant CBDP (Fig. 1) reduced in a concentration-dependent and drastic fashion the
amount of caveolin which was coimmunoprecipitated with
pp59Lyn and, vice versa, the amount of
pp59Lyn which was coimmunoprecipitated with
caveolin (Fig. 2). The apparent dissociation of
pp59Lyn from caveolin residing in DIG was also
reflected in the loss of pp59Lyn from total
adipocyte caveolin immunoprecipitates as well as total (nondissociated)
DIG in response to increasing concentrations of CBDP (Fig.
3A). It correlated well to pronounced
increases in tyrosine phosphorylation and activity (toward
exogenous substrate) of total immunoprecipitated
pp59Lyn (Fig. 3B) as well as tyrosine
phosphorylation of total cellular IRS-1 and
pp125Fak with about the same concentration
dependence (apparent 50% effective concentration
[EC50] = 10 to 30 µM; Fig. 2). Homologous
immunoblotting of the caveolin immunoprecipitates demonstrated similar
efficiency of the immunoprecipitations. Stimulation of total IRS-1
tyrosine phosphorylation by wild-type but not mutant CBDP was strongly correlated to IRS-1-associated PI-3'K activity and glucose transport (Fig. 4). As expected, a control
incubation of intact rat adipocytes with 300 µM CBDP omitting
electroporation failed to induce
pp59Lyn-caveolin dissociation and
insulin-mimetic signaling, arguing for an intracellular site of action
of CBDP.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 2.
Intracellular CBDP causes dissociation of
pp59Lyn and caveolin in DIG. Isolated rat adipocytes were
electroporated in the absence or presence of different concentrations
of wild-type or mutant CBDP derived from pp59Lyn. From
portions of total-cell lysates, DIG were prepared (detergent method)
and used for immunoprecipitation (IP) (dissociating conditions) of
pp59Lyn and caveolin. From other portions of the lysates,
pp125Fak and IRS-1 were immunoprecipitated. The
immunoprecipitates were immunoblotted (IB) for caveolin,
pp59Lyn, and phosphotyrosine by immunoblotting using
chemiluminescent detection. Shown are phosphorimages of a typical
experiment that was repeated three times, with similar results.
|
|

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 3.
CBDP and PIG affect pp59Lyn tyrosine
phosphorylation and its activity and interaction with caveolin in a
similar fashion. Isolated rat adipocytes were electroporated or
incubated (20 min, 37°C) in the absence or presence of increasing
concentrations of wild-type or mutant CBDP derived from
pp59Lyn (A, B) or PIG 41 and PIG 1 (B). From portions of
total-cell lysates, DIG were prepared (detergent method) and used for
direct immunoblotting (IB) of pp59Lyn (A) or
immunoprecipitation (IP) (nondissociating conditions) of caveolin (B).
From other portions of the lysates, caveolin (A) and
pp59Lyn (B) were immunoprecipitated. The immunoprecipitates
were immunoblotted for pp59Lyn and phosphotyrosine (pY) or
measured for pp59Lyn activity by the immune complex kinase
assay. (A) Shown are phosphorimages of a typical experiment that was
repeated two times, with similar results. (B) Quantitative evaluations
of three different adipocyte incubations with measurements in
triplicate each are given as the percentage of maximum or fold
stimulation (mean plus standard deviation), with basal values set at
100% or 1.
|
|

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 4.
Intracellular CBDP causes stimulation of IRS-1 tyrosine
phosphorylation, PI-3'K, and glucose transport. Isolated rat adipocytes
were electroporated in the absence or presence of increasing
concentrations of wild-type CBDP derived from pp59Lyn. From
portions of the cells, total lysates were prepared and used for
immunoprecipitation (IP) of IRS-1. The immunoprecipitates were
immunoblotted (IB) for phosphotyrosine (pY) or assessed for associated
PI-3'K activity by the immune complex kinase assay. Other portions of
the cells were assayed for 2-deoxyglucose transport. Quantitative
evaluations of three different adipocyte incubations with measurements
in quadruplicate each are given as fold stimulation (mean ± standard deviation), with basal values set at 1.
|
|
Interestingly, a similar decline in the interaction between
pp59
Lyn and caveolin in DIG and a concomitant
increase in tyrosine phosphorylation
and activation of total
immunoprecipitated pp59
Lyn was observed after
incubation of rat adipocytes with the active
insulin-mimetic PIG 41 (
17,
18,
45) but not the inactive
PIG 1 (Fig.
3B).
However, about 100-fold-lower concentrations
of PIG 41 than of
wild-type CBDP were sufficient. This suggests
that intracellular CBDP
derived from pp59
Lyn and exogenous active PIG
trigger insulin-mimetic signaling and
metabolic action in isolated rat
adipocytes by similar mechanisms
involving dissociation of
pp59
Lyn from caveolin in DIG. To test this
hypothesis, DIG of isolated
rat adipocytes incubated with structurally
different PIG were
assayed for caveolin-associated
pp59
Lyn, pp125
Fak (by
immunoblotting), and Gce1 (by photoaffinity labeling with
8-N
3-[
32P]cAMP; Fig.
5). The amounts of
pp125
Fak, pp59
Lyn, and Gce1
recovered with caveolin immunoprecipitates from DIG
were reduced by up
to 60 and 80% in response to PIG 41 and 37,
respectively (Fig.
5A and
B). PIG 7 and 1 were less efficient
(pp59
Lyn and
Gce1) or even inactive (pp125
Fak). Comparable
efficiency of caveolin immunoprecipitation was shown
by homologous
immunoblotting. Thus, the insulin-mimetic potency
of active PIG
correlates with their ability to disrupt the
caveolin-pp59
Lyn,
-pp125
Fak, and -Gce1 interactions.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 5.
PIG causes dissociation of pp125Fak,
pp59Lyn, and Gce1 from caveolin in DIG. Isolated rat
adipocytes were incubated (20 min, 37°C) with 10 µM PIG 41, 37, 7, or 1. DIG were prepared from total-cell lysates (detergent method) and
used for immunoprecipitation (IP) (nondissociating conditions) of
caveolin. The immunoprecipitates were immunoblotted (IB) for
pp125Fak, pp59Lyn, and caveolin or assayed for
Gce1 by photoaffinity labeling with
8-N3-[32P]cAMP. (A) Shown are phosphorimages
of a typical experiment that was repeated two times, with similar
results. (B) Quantitative evaluations of three different adipocyte
incubations with measurements in triplicate each are given as the
percent of maximal response (mean ± standard deviation), with
basal values (absence of PIG) set at 100%.
|
|
Dissociation of this interaction by CBDP may be overcome by an excess
of intracellular CSDP. In fact, the almost complete
loss of Gce1 and
pp125
Fak along with pp59
Lyn
from caveolin residing in DIG upon introduction of CBDP into
adipocytes
was completely blocked by a simultaneous electroporation
of a threefold
molar excess of CSDP (Fig.
6). This
argues for
the neutralization of CBDP action by direct binding to CSDP.
Apparently,
CSDP not bound to CBDP does not compete with endogenous
caveolin
for interaction with CBD of pp59
Lyn.
This may be explained by a higher affinity of CSD in the context
of
native DIG-embedded caveolin. Excess of CSDP (up to 100-fold)
impaired
the PIG 41-induced release from DIG-associated caveolin
of
pp125
Fak to only a low degree and that of
pp59
Lyn and Gce1 not at all (Fig.
6). Thus, CBDP
and active PIG apparently
differ in the mechanism interfering with the
caveolin-signaling
component interaction, PIG indirectly (possibly via
signaling
processes within caveolae-DIG) rather than physically.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 6.
CSDP blocks CBDP-induced but not PIG-induced
dissociation of Gce1, pp59Lyn, and pp125Fak
from caveolin. Isolated rat adipocytes were electroporated in the
absence or presence of various concentrations of CSDP and/or CBDP and
then were incubated (20 min, 37°C) with or without 3 µM PIG 41 as
indicated. DIG were prepared from total-cell lysates (detergent method)
and used for immunoprecipitation (IP) (nondissociating conditions) of
caveolin. The immunoprecipitates were assessed for the presence of Gce1
by photoaffinity labeling and assessed for the presence of
pp59Lyn and pp125Fak by immunoblotting (IB)
using chemiluminescent detection. Shown are phosphorimages of a typical
experiment that was repeated two times, with similar results.
|
|
Tyrosine phosphorylation of caveolin and its dissociation from
pp59Lyn, pp125Fak, and Gce1 are
correlated.
The concentration-dependent dissociation of
pp59Lyn, pp125Fak, and Gce1
from caveolin in DIG can also be followed with total adipocyte caveolin
(Fig. 7). Upon treatment of adipocytes
with different PIG, the decline in interaction correlated well to the
increase in tyrosine phosphorylation of caveolin immunoprecipitated
from total-cell lysates both with regard to the similar
EC50 values (1 to 3 µM) and with the ranking
between PIG 41 and 37. PIG 1 did not elicit caveolin tyrosine
phosphorylation. Thus, in adipocytes, tyrosine phosphorylation of
caveolin may be causally related to its dissociation from
pp59Lyn, pp125Fak, and
Gce1. Candidate kinases are Src family members since
insulin-dependent caveolin tyrosine phosphorylation by
pp60v-src and
pp59Fyn has been described (22, 33,
36). In this case, a positive feedback loop between kinase
activation and dissociation from caveolin and tyrosine phosphorylation
of caveolin may be initiated.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 7.
PIG-induced dissociation of Gce1, pp125Fak,
and pp59Lyn from caveolin correlates to caveolin tyrosine
phosphorylation. Isolated rat adipocytes were incubated (20 min,
37°C) with increasing concentrations of PIG 41, 37, or 1. From
total-cell lysates, caveolin was immunoprecipitated (IP). The
immunoprecipitates were assayed for the presence of Gce1 by
photoaffinity labeling or for the presence of pp125Fak,
pp59Lyn, phosphotyrosine (pY), and caveolin by
immunoblotting (IB). Shown are quantitative evaluations of three
different adipocyte incubations with measurements taken in
quadruplicate, and results are given as a ratio of the relative amount
of caveolin (mean ± standard deviation) or as the fold
stimulation (mean ± standard deviation), with basal
values set at 1.
|
|
CSDP blocks PIG-induced tyrosine phosphorylation and glucose
transport activation.
In agreement with the caveolin signaling
hypothesis (34, 49), the above data hint to a negative
regulatory function of caveolin on pp59Lyn. To
further substantiate the involvement of caveolin in
pp59Lyn inhibition and its antagonism by active
PIG, we studied the effect of CSDP on pp59Lyn
tyrosine phosphorylation (Fig. 8A) and
downstream signaling events (Fig. 8B) after introduction into isolated
rat adipocytes. As demonstrated previously (44), PIG 7, 37, and 41 induced tyrosine phosphorylation of total immunoprecipitated
pp59Lyn in a concentration-dependent fashion,
with PIG 41 being most effective, followed by PIG 37 and, lastly, PIG
7. PIG-induced tyrosine phosphorylation was reduced by wild-type CSDP
in a concentration-dependent fashion, with a 50% inhibitory
concentration of 30 µM irrespective of the PIG concentration
used (Fig. 8A and B). Inhibition of tyrosine phosphorylation of total immunoprecipitated
pp59Lyn, pp125Fak, and
IRS-1 as well as glucose transport in response to PIG 41 (2 µM)
by CSDP were well correlated (Fig. 8B). Thus, cytoplasmic wild-type
CSDP can act as an efficient inhibitor of PIG stimulation of
pp59Lyn, insulin-mimetic signaling (IRS-1
tyrosine phosphorylation), and insulin-mimetic action (glucose
transport based on translocation of Glut4 and Glut1 from intracellular
vesicles to the plasma membrane as reported previously
[18]). Since CSDP does not interfere with PIG-induced
release of pp59Lyn and
pp125Fak from caveolin (Fig. 6), it presumably
acts via dominant-negative binding to
pp59Lyn upon relief of the latter from
inhibition by endogenous caveolin.

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 8.
CSDP impairs PIG-induced tyrosine phosphorylation of
pp59Lyn (A) and tyrosine phosphorylation of
pp125Fak and IRS-1 and glucose transport (B). Isolated rat
adipocytes were electroporated in the absence of CSDP or presence of
increasing concentrations of CSDP and then incubated (20 min, 37°C)
with increasing concentrations of PIG 41, 37, and 7 (A) or 2 µM PIG
41 (B). From portions of the cells, pp59Lyn (A, B) and
pp125Fak and IRS-1 (B) were immunoprecipitated (IP) from
total-cell lysates and were immunoblotted (IB) for phosphotyrosine
(pY). (A) Shown are phosphorimages of a typical experiment that was
repeated three times, with similar results. (B) Other portions of the
cells were assayed for 2-deoxyglucose transport. Shown are quantitative
evaluations of four different adipocyte incubations with measurements
in duplicate, and results are given as the percent of PIG response
(mean ± standard deviation), set at 100% in the absence of
CSDP.
|
|
PIG trigger redistribution of pp59Lyn,
pp125Fak, and Gce1 from DIG to non-DIG areas.
The
observation that active PIG trigger the dissociation of a specific set
of proteins from caveolin in adipocytes raised the question about their
destination. Therefore, we studied whether these polypeptides leave the
DIG and move to other regions of the plasma membrane which do not
harbor DIG according to the criterion of detergent or carbonate
insolubility (non-DIG areas) or translocate to intracellular membranes
or the cytosol. The non-DIG areas are characterized by significant
deprivement of caveolin, 5'-nucleotidase, Gce1, and
pp59Lyn versus both total plasma membranes and
DIG, as well as significant enrichment of
Na+/K+-ATPase and
-actin
versus DIG (Table 1). Glut1, Glut4, and IR
were distributed about
equally between DIG and non-DIG areas. Thus, in isolated rat
adipocytes, non-DIG areas represent the typical overall
plasma membranes harboring the majority of plasma membrane proteins but
lacking typical caveolar or DIG components. Figure
9A demonstrates that the
concentration-dependent decrease in the amount of Gce1,
pp59Lyn, and pp125Fak in
DIG in response to PIG 41 was in parallel to their increase in non-DIG
areas isolated from the same adipocytes. Quantitative evaluation
confirmed the inverse relationship between the disappearance and
appearance of Gce1, pp59Lyn, and
pp125Fak in DIG and non-DIG areas, respectively,
in response to PIG 41 with similar EC50 (0.3 to 1 µM) for all three proteins (Fig. 9B). PIG treatment did not affect
the distribution of caveolin, IR
, and Glut4 between DIG (Fig. 9A)
and non-DIG areas and was not associated with a considerable shift of
Gce1, pp59Lyn, and pp125Fak
to intracellular membranes or the cytosol (data not shown). In agreement with the failure of CSDP to impair the PIG-induced
dissociation of pp59Lyn from caveolin (Fig. 6), a
30-fold molar excess of CSDP over PIG 41 did not affect redistribution
of pp59Lyn from DIG to non-DIG areas (Fig.
10). Taken together, active PIG trigger
pronounced redistribution of Gce1, pp59Lyn, and
pp125Fak from DIG to non-DIG areas of the
adipocyte plasma membrane.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 9.
PIG induces redistribution of Gce1, pp59Lyn,
and pp125Fak from DIG to non-DIG areas of the plasma
membrane. Isolated rat adipocytes were incubated (20 min, 37°C) with
increasing concentrations of PIG 41. From total plasma membranes, DIG
and non-DIG areas were prepared (carbonate method), purified (sucrose
gradient centrifugation), and then immunoblotted (IB) for
pp59Lyn, pp125Fak, caveolin, IR , and Glut4
or assayed for Gce1 by photoaffinity labeling. (A) Shown are
phosphorimages of a typical experiment that was repeated two times,
with similar results. (B) Shown are quantitative evaluations of three
different adipocyte incubations with measurements in duplicate, and
results are given as the percentage of total material contained in DIG
( ) plus non-DIG ( ) areas (mean ± standard deviation), with
basal values (absence of PIG 41) set at 100%.
|
|

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 10.
CSDP does not interfere with PIG-induced redistribution
of pp59Lyn from DIG to non-DIG areas. Isolated rat
adipocytes were electroporated in the absence or presence of 300 µM
CSDP and then incubated (20 min, 37°C) with increasing concentrations
of PIG 41. From total plasma membranes, DIG and non-DIG areas were
prepared (carbonate method), purified (sucrose gradient
centrifugation), and then immunoblotted (IB) for pp59Lyn.
Shown are phosphorimages of a typical experiment that was repeated
once, with similar results.
|
|
pp125Fak interacts with pp59Lyn, IRS-1, and
Gce1 during PIG-induced redistribution.
Previous studies on the
mechanism of insulin receptor-independent tyrosine phosphorylation of
IRS-1 in response to PIG showed that pp125Fak
acts as a platform molecule for PIG-dependent recruitment of pp59Lyn and IRS-1 (44). The present
observation of PIG-dependent redistribution of
pp59Lyn, Gce1, and pp125Fak
raised the possibility of their interaction after arrival at non-DIG
areas. In fact, treatment of isolated rat adipocytes with PIG 41 increased, in a concentration-dependent manner, the amounts of
pp59Lyn, Gce1, and IRS-1 which were
coimmunoprecipitated with pp125Fak from non-DIG
areas (Fig. 11). The efficiency of
pp125Fak immunoprecipitation did not vary
significantly. The (small) amounts of
1-integrin, paxillin (a major cytoskeletal
substrate of pp125Fak), and IR
recovered with
pp125Fak in non-DIG areas did not elevate during
the course of PIG treatment. Thus, PIG-stimulated redistribution of
pp59Lyn and Gce1 from DIG to non-DIG areas is
accompanied by their association with pp125Fak
and IRS-1. This provides further evidence for
pp125Fak functioning as a recruitment platform
during PIG signaling.

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 11.
PIG induces complex formation between
pp125Fak, pp59Lyn, IRS-1, paxillin, and Gce1.
Isolated rat adipocytes were incubated (20 min, 37°C) in the absence
or presence of increasing concentrations of PIG 41. From total-cell
lysates, non-DIG areas were prepared (detergent method) and then used
for immunoprecipitation (IP) (nondissociating conditions) of
pp125Fak. The immunoprecipitates were subsequently
immunoblotted (IB) for pp125Fak, 1-integrin,
pp59Lyn, IRS-1, paxillin, and IR or assayed for Gce1 by
photoaffinity labeling. Shown are phosphorimages of a typical
experiment that was repeated two times, with similar results.
|
|
CSDP does not block insulin signaling and action.
Insulin has
been reported to cause partial activation of NRTK of the Src family
(pp59Fyn) in 3T3-L1 adipocytes (29,
36). However, its relevance for metabolic insulin action
remained unclear. It was conceivable that insulin and PIG activation of
PI-3'K operate in part via the same molecular mechanism. Therefore, we
studied whether CSDP manages to inhibit insulin stimulation of glucose
transport and IRS-1 tyrosine phosphorylation (Table
2). As expected, electroporation of
isolated rat adipocytes with CSDP inhibited, in a
concentration-dependent manner, IRS-1 tyrosine phosphorylation and
glucose transport activation in response to both CBDP and PIG 41. In
contrast, CSDP failed to suppress insulin signaling and metabolic
action to any significant degree, even at 300 µM and at submaximal
insulin concentrations. This argues for the specificity of the CSDP
inhibitory action and strongly suggests that insulin does not use
the same signaling pathway upstream of IRS-1 as active PIG involving
the modulation of the caveolin-pp59Lyn
interaction.
 |
DISCUSSION |
It has been proposed that caveolins and, by implication,
caveolae and DIG may act to coordinate the interaction of receptors and
a variety of downstream signal-transducing molecules that localize to
the plasma membrane following cell stimulation (41, 49,
60). Agonist stimulation has been demonstrated to result in
redistribution of receptors for contractile agonists (e.g., bradykinin
[13] and acetylcholine [16]), hormones
(e.g., insulin [24] and angiotensin II
[25]), and growth factors (e.g., epidermal growth factor
[11]), as well as of downstream elements (e.g., protein
kinase C
[37] and rhoA
[63]) to caveolin-containing subcellular fractions,
which for rhoA was shown to be inhibited by the CSDP
(63).
Our studies with isolated rat adipocytes have revealed the induction
and regulation of the opposite movement of signaling components. The
NRTK, pp59Lyn, pp125Fak,
and the GPI protein, Gce1, translocate from DIG to non-DIG areas of the
plasma membrane in response to (i) an extracellular stimulus, insulin-mimetic PIG molecules, and (ii) intracellular accumulation of
CBDP derived from pp59Lyn. This movement is based
on interference (indirectly or directly, respectively) with the
caveolin(CSD)-NRTK(CBD) interaction. It correlates well to increased
tyrosine phosphorylation and activity of pp59Lyn
and pp125Fak and is accompanied by elevated
tyrosine phosphorylation of IRS-1, PI-3'K activity, and glucose
transport. In contrast, CSDP blocked PIG-induced tyrosine
phosphorylation of pp59Lyn,
pp125Fak, and IRS-1 as well as glucose transport
and can therefore be used as a specific inhibitor to test for
involvement of the PIG signaling pathway. These findings suggest a
causal relationship between the interaction with caveolin, localization
in DIG-caveolae, and low activity of Gce1,
pp59Lyn, and pp125Fak and
vice versa between their dissociation from caveolin, redistribution from DIG-caveolae to plasma membrane non-DIG areas, and insulin-mimetic signaling.
In vivo, PIG molecules as a putative physiological signal may be
generated by lipolytic cleavage of GPI proteins at the outer face of
the plasma membrane, which, in fact, has been reported for primary and
cultured adipose, muscle, and endothelial cells in response to a number
of hormones and growth factors, such as insulin and nerve growth factor
(38, 39), glucose (1, 39), and the drug
glimepiride (38, 39). Alternatively, degradation products
of free GPI lipids concentrated in DIG-caveolae may act in a similar
fashion as the synthetic PIG used in the present study. In different
cellular systems, lipolytic GPI turnover is modulated by a variety of
hormones, cytokines, and growth factors, such as insulin,
interleukin-2, epidermal growth factor, and erythropoietin (4, 9,
26). Treatment of intact rat adipocytes with bacterial (G)PI-specific phospholipase C induces some insulin effects
(35) and tyrosine phosphorylation of caveolin but
not of the insulin receptor (42). However, redistribution
of caveolar components in response to GPI cleavage remains to be studied.
pp125Fak released from DIG-caveolae is
phosphorylated at tyrosines, presumably in an
autophosphorylation reaction (Tyr397) and by
pp59Lyn (Tyr576, Tyr577). This ensures proper
interaction of the two kinases (6) and maximal activation
of pp125Fak (44), respectively.
pp125Fak is known to function as a platform
molecule for signal-dependent recruitment of a number of signaling
molecules, including IRS-1 and IRS-2 (62). This
finding was confirmed and extended here by the
demonstration of complex formation between
pp125Fak, pp59Lyn, IRS-1,
and Gce1, but not the cytoskeletal proteins, paxillin, and
1-integrin, in response to PIG. Thus, Gce1,
pp59Lyn, and pp125Fak
together with IRS-1 and IRS-2 may be redistributed from caveolae to a
multicomponent signaling module where tyrosine-phosphorylated and
activated pp125Fak may present IRS-1 and IRS-2
for phosphorylation at specific tyrosine residues by activated
pp59Lyn. This in turn initiates signaling to the
Glut4 and Glut1 translocation apparatus and other metabolic effector
systems which also receive their insulin signals from the IRS proteins
(23, 47). Apparently, IRS-1 acts as site of convergence of
the signaling pathways initiated by insulin-mimetic PIG and insulin.
These are clearly separate upstream of IRS-1 based on the ability of
CSDP to block PIG but not insulin signaling and action. It is clear
from studies with CSDP that relief of pp59Lyn
from interaction with or inhibition by caveolin is required for insulin-mimetic PIG signaling and action. However, the signal emerging
from this pathway and ultimately resulting in potent PI-3'K activation
may not be sufficient for glucose transport stimulation by PIG.
Furthermore, the PIG pathway may operate not only in adipose but also
muscle cells since they both express a high number of caveolae
(2), which is a prerequisite and may guarantee specificity
for metabolic coupling. Future experiments have to address these possibilities.
The PIG signaling module upstream of IRS-1 seems to be used by other
ligands or pathways since clustering of the adipocyte-specific integrins
5 and
1 by
fibronectin plus activating anti-
1-antibody blocked PIG-induced tyrosine phosphorylation of
pp59Lyn and IRS-1 via interference at
pp125Fak (44). Thus, the
Gce1-pp125Fak-pp59Lyn-IRS-1-IRS-2
complex may represent the site for the integration of at least two
pathways for extracellular signals leading to insulin-mimetic metabolic
signaling. One of the pathways acts from GPI proteins via caveolae-DIG
in a positive fashion, and the other pathway acts from the
extracellular matrix via integrins in a negative fashion. Localization
of the activated signaling module at sites different from both
caveolae-DIG and integrins at non-DIG areas may favor this cross talk.
Our finding may be of relevance for the elucidation of novel approaches
for the therapy of insulin-resistant states which are manifested during
metabolic syndrome and type II diabetes mellitus (8).
Reduced responsiveness and sensitivity of components of the insulin
signaling pathway toward insulin can be observed already immediately
downstream of the insulin receptor at the level of tyrosine
phosphorylation of IRS-1 and IRS-2 (30). Consequently, insulin receptor-independent tyrosine phosphorylation of IRS-1 and
IRS-2 mediated by cross talk from the GPI
protein-DIG-caveola-pp59Lyn pathway should
induce insulin-mimetic effects, such as stimulation of glucose
uptake, in insulin-resistant adipose and muscle cells. This has been
demonstrated so far for PIG in adipocytes isolated from obese rats
(18). Thus, small molecules which cause redistribution of
caveolar or DIG components may be useful for the therapy of metabolic
syndrome and type II diabetes mellitus.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Aventis Pharma
Germany GmbH, Disease Group Metabolic Diseases, Bldg. H825, 65926 Frankfurt am Main, Germany. Phone: 4969-305-4271. Fax: 4969-305-81901. E-mail: Guenter.Mueller{at}aventis.com.
 |
REFERENCES |
| 1.
|
Accardo-Palumbo, A.,
G. Triolo,
G. Colonna-Romano,
M. Potestio,
M. Carbone,
A. Ferrante,
E. Giardina,
G. Caimi, and G. Triolo.
2000.
Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells.
Diabetologia
43:1039-1047[CrossRef][Medline].
|
| 2.
|
Anderson, R. G. W.
1998.
The caveolae membrane system.
Annu. Rev. Biochem.
67:199-225[CrossRef][Medline].
|
| 3.
|
Bickel, P. E.,
P. E. Scherer,
J. E. Schnitzer,
P. Oh,
M. P. Lisanti, and H. F. Lodish.
1997.
Flotillin and epidermal surface antigen define a new famly of caveolae-associated integral membrane proteins.
J. Biol. Chem.
272:13793-13802[Abstract/Free Full Text].
|
| 4.
|
Boudot, C.,
E. Petitfrere,
Z. Kadri,
S. Chretien,
P. Mayeux,
B. Haye, and C. Billat.
1999.
Erythropoietin induces glycosylphosphatidylinositol hydrolysis.
J. Biol. Chem.
274:33966-33972[Abstract/Free Full Text].
|
| 5.
|
Brown, D. A., and E. London.
1998.
Structure and origin of ordered lipid domains in biological membranes.
J. Membr. Biol.
164:103-114[CrossRef][Medline].
|
| 6.
|
Calalb, M. B.,
T. R. Polte, and S. K. Hanks.
1995.
Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases.
Mol. Cell. Biol.
15:954-963[Abstract].
|
| 7.
|
Carman, C. V.,
M. P. Lisanti, and J. L. Benovic.
1999.
Regulation of G protein-coupled receptor kinases by caveolin.
J. Biol. Chem.
274:8858-8864[Abstract/Free Full Text].
|
| 8.
|
Carvalho, E.,
B. Eliasson,
C. Wesslau, and U. Smith.
2000.
Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B/Akt in adipocytes from type II diabetic subjects.
Diabetologia
43:1107-1115[CrossRef][Medline].
|
| 9.
|
Clemente, R.,
D. R. Jones,
P. Ochoa,
G. Romero,
J. M. Mato, and I. Varela-Nieto.
1995.
Role of glycosyl-phosphatidylinositol hydrolysis as a mitogenic signal for epidermal growth factor.
Cell. Signal.
7:411-421[CrossRef][Medline].
|
| 10.
|
Couet, J.,
S. Li,
T. Okamoto,
T. Ikezu, and M. P. Lisanti.
1997.
Identification of peptide and protein ligands for the caveolin-scaffolding domain.
J. Biol. Chem.
272:6525-6533[Abstract/Free Full Text].
|
| 11.
|
Couet, J.,
M. Sargiacomo, and M. P. Lisanti.
1997.
Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities.
J. Biol. Chem.
272:30429-30438[Abstract/Free Full Text].
|
| 12.
|
Das, K.,
R. Y. Lewis,
P. E. Scherer, and M. P. Lisanti.
1999.
The membrane spanning domains of caveolins 1 and 2 mediate the formation of caveolin hetero-oligomers. Implications for the assembly of caveolae membranes in vivo.
J. Biol. Chem.
274:18721-18726[Abstract/Free Full Text].
|
| 13.
|
de Weerd, W. F. C., and L. M. F. Leeb-Lundberg.
1997.
Bradykinin sequesters B2 bradykinin receptors and the receptor coupled G subunits G q and G i in caveolae in DDT1 MF-2 smooth muscle cells.
J. Biol. Chem.
272:17858-17866[Abstract/Free Full Text].
|
| 14.
|
Engelman, J. A.,
C. Chu,
A. Lin,
H. Jo,
T. Ikezu,
T. Okamoto,
D. S. Kohtz, and M. P. Lisanti.
1998.
Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain.
FEBS Lett.
428:205-211[CrossRef][Medline].
|
| 15.
|
Engelman, J. A.,
C. C. Wykoff,
S. Yasuhara,
K. S. Song,
T. Okamoto, and M. P. Lisanti.
1997.
Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth.
J. Biol. Chem.
272:16374-16381[Abstract/Free Full Text].
|
| 16.
|
Feron, O.,
T. W. Smith,
T. Michel, and R. A. Kelly.
1997.
Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes.
J. Biol. Chem.
272:17744-17748[Abstract/Free Full Text].
|
| 17.
|
Frick, W.,
A. Bauer,
J. Bauer,
S. Wied, and G. Müller.
1998.
Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes.
Biochem. J.
336:163-181.
|
| 18.
|
Frick, W.,
A. Bauer,
J. Bauer,
S. Wied, and G. Müller.
1998.
Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action.
Biochemistry
37:13421-13436[CrossRef][Medline].
|
| 19.
|
Galbiati, F.,
D. Volonte,
J. A. Engelman,
G. Watanabe,
R. Burk,
R. G. Pestell, and M. P. Lisanti.
1998.
Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade.
EMBO J.
17:6633-6648[CrossRef][Medline].
|
| 20.
|
Garcia-Cardena, G.,
P. Martasek,
B. S. Siler-Masters,
P. M. Skidd,
J. C. Couet,
S. Li,
M. P. Lisanti, and W. C. Sessa.
1997.
Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: functional significance of the NOS caveolin binding domain in vivo.
J. Biol. Chem.
272:25437-25440[Abstract/Free Full Text].
|
| 21.
|
Glenney, J. R.
1992.
The sequence of human caveolin reveals identity with VIP 21, a component of transport vesicles.
FEBS Lett.
314:45-48[CrossRef][Medline].
|
| 22.
|
Glenney, J. R.
1989.
Tyrosine phosphorylation of a 22 kD protein is correlated with transformation with Rous sarcoma virus.
J. Biol. Chem.
264:20163-20166[Abstract/Free Full Text].
|
| 23.
|
Gustafson, T. A.,
S. A. Moodie, and B. E. Lavan.
1998.
The insulin receptor and metabolic signaling.
Rev. Physiol. Biochem. Pharmacol.
137:71-192.
|
| 24.
|
Gustavsson, J.,
S. Parpal,
M. Karlsson,
C. Ramsing,
H. Thorn,
M. Borg,
M. Lindroth,
K. H. Peterson,
K.-E. Magnusson, and P. Stralfors.
1999.
Localization of the insulin receptor in caveolae of adipocyte plasma membrane.
FASEB J.
13:1961-1971[Abstract/Free Full Text].
|
| 25.
|
Ishizaka, N.,
K. K. Griendling,
B. Lassegue, and R. W. Alexander.
1998.
Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation.
Hypertension
32:459-466[Abstract/Free Full Text].
|
| 26.
|
Jones, D. R., and I. Varela-Nieto.
1999.
Diabetes and the role of inositol-containing lipids in insulin signaling.
Mol. Med.
5:505-514[Medline].
|
| 27.
|
Ju, H.,
R. Zou,
V. J. Venema, and R. C. Venema.
1997.
Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity.
J. Biol. Chem.
272:18522-18525[Abstract/Free Full Text].
|
| 28.
|
Koleske, A.,
J. D. Baltimore, and M. P. Lisanti.
1995.
Reduction of caveolin and caveolae in oncogenically transformed cells.
Proc. Natl. Acad. Sci. USA
92:1381-1385[Abstract/Free Full Text].
|
| 29.
|
Lebrun, P.,
I. Mothe-Satney,
L. Delahaye,
E. van Obberghen, and V. Baron.
1998.
Insulin receptor substrate-1 as a signaling molecule for focal adhesion kinase pp125Fak and pp60src.
J. Biol. Chem.
273:32244-32253[Abstract/Free Full Text].
|
| 30.
|
Le Marchand-Brustel, Y.,
J.-F. Tanti,
M. Cormont,
J.-M. Ricort,
T. Gremeaux, and S. Grillo.
1999.
From insulin receptor signalling to GLUT4 translocation abnormalities in obesity and insulin resistance.
J. Recept. Signal Transduct. Res.
19:217-228[Medline].
|
| 31.
|
Li, S.,
J. Couet, and M. P. Lisanti.
1996.
Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases.
J. Biol. Chem.
272:29182-29190.
|
| 32.
|
Li, S.,
T. Okamoto,
M. Chun,
M. Sargiacomo,
J. E. Casanova,
S. H. Hansen,
I. Nishimoto, and M. P. Lisanti.
1995.
Evidence for a regulated interaction between heteromeric G proteins and caveolin.
J. Biol. Chem.
270:15693-15701[Abstract/Free Full Text].
|
| 33.
|
Li, S.,
R. Seitz, and M. P. Lisanti.
1996.
Phosphorylation of caveolin by Src tyrosine kinases: the alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo.
J. Biol. Chem.
271:3863-3868[Abstract/Free Full Text].
|
| 34.
|
Lisanti, M. P.,
P. E. Scherer,
Z. L. Tang, and M. Sargiacomo.
1994.
Caveolae, caveolin and caveolin-rich membrane domains: a signaling hypothesis.
Trends Cell Biol.
4:231-235[CrossRef][Medline].
|
| 35.
|
Macaulay, S. L., and R. G. Larkins.
1990.
Phospholipase C mimics insulin action on pyruvate dehydrogenase and insulin mediator generation but not glucose transport or utilization.
Cell. Signal.
2:9-19[CrossRef][Medline].
|
| 36.
|
Mastick, C. C.,
M. J. Brady, and A. R. Saltiel.
1995.
Insulin stimulates the tyrosine phosphorylation of caveolin.
J. Cell Biol.
129:1523-1531[Abstract/Free Full Text].
|
| 37.
|
Mineo, C.,
Y.-S. Ying,
C. Chapline,
S. Jaken, and R. G. W. Anderson.
1998.
Targeting of protein kinase C alpha to caveolae.
J. Cell Biol.
141:601-610[Abstract/Free Full Text].
|
| 38.
|
Movahedi, S., and N. Hooper.
1997.
Insulin stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a phospholipase C.
Biochem. J.
326:531-537.
|
| 39.
|
Müller, G.,
E.-A. Dearey,
A. Korndörfer, and W. Bandlow.
1994.
Stimulation of a glycosyl phosphatidylinositol-specific phospholipase by insulin and the sulfonylurea, glimepiride, in rat adipocytes depends on increased glucose transport.
J. Cell Biol.
126:1267-1276[Abstract/Free Full Text].
|
| 40.
|
Müller, G.,
J. Ertl,
M. Gerl, and G. Preibisch.
1997.
Leptin impairs metabolic actions of insulin in isolated rat adipocytes.
J. Biol. Chem.
272:10585-10593[Abstract/Free Full Text].
|
| 41.
|
Müller, G., and W. Frick.
1999.
Signalling via caveolin: involvement in the cross-talk between phosphoinositolglycans and insulin.
Cell. Mol. Life Sci.
56:945-970[CrossRef][Medline].
|
| 42.
|
Müller, G., and K. Geisen.
1996.
Characterization of the molecular mode of the sulfonylurea, glimepiride, at adipocytes.
Horm. Metab. Res.
28:469-487[Medline].
|
| 43.
|
Müller, G.,
E.-A. Wetekam,
C. Jung, and W. Bandlow.
1994.
Membrane association of lipoprotein lipase and a cAMP-binding ectoprotein in rat adipocytes.
Biochemistry
33:12149-12159[CrossRef][Medline].
|
| 44.
|
Müller, G.,
S. Wied, and W. Frick.
2000.
Cross talk of pp125FAK and pp59Lyn non-receptor tyrosine kinases to insulin-mimetic signaling in adipocytes.
Mol. Cell. Biol.
20:4708-4723[Abstract/Free Full Text].
|
| 45.
|
Müller, G.,
S. Wied,
C. Piossek,
A. Bauer,
J. Bauer, and W. Frick.
1998.
Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans.
Mol. Med.
4:299-323[Medline].
|
| 46.
|
Nosjean, O.,
A. Briolay, and B. Roux.
1997.
Mammalian GPI proteins: sorting, membrane residence and functions.
Biochim. Biophys. Acta
1331:153-186[Medline].
|
| 47.
|
Nystrom, F. H., and M. J. Quon.
1999.
Insulin signalling: metabolic pathways and mechanisms for specificity.
Cell. Signal.
11:563-574[CrossRef][Medline].
|
| 48.
|
Oka, N.,
M. Yamamoto,
C. Schwencke,
J. Kawabe,
T. Ebina,
S. Ohno,
J. Couet,
M. P. Lisanti, and Y. Ishikawa.
1997.
Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the scaffolding domain peptide.
J. Biol. Chem.
272:33416-33421[Abstract/Free Full Text].
|
| 49.
|
Okamoto, T.,
A. Schlegel,
P. E. Scherer, and M. P. Scherer.
1998.
Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.
J. Biol. Chem.
273:5419-5422[Free Full Text].
|
| 50.
|
Parton, R. G.
1996.
Caveolae and caveolins.
Curr. Opin. Cell Biol.
8:542-548[CrossRef][Medline].
|
| 51.
|
Razani, B.,
C. S. Rubin, and M. P. Lisanti.
1999.
Regulation of cAMP-mediated signal transduction via interaction of caveolins with the catalytic subunit of protein kinase A.
J. Biol. Chem.
274:26353-26360[Abstract/Free Full Text].
|
| 52.
|
Resh, M. D.
1998.
Fyn, a Src family tyrosine kinase.
Int. J. Biochem. Cell Biol.
30:1159-1162[CrossRef][Medline].
|
| 53.
|
Rietveld, A., and K. Simons.
1998.
The differential miscibility of lipids as the basis for the formation of functional membrane rafts.
Biochim. Biophys. Acta
1376:467-479[Medline].
|
| 54.
|
Rothberg, K. G.,
J. E. Henser,
W. C. Donzell,
Y.-S. Ying,
J. R. Glenney, and R. G. W. Anderson.
1992.
Caveolin, a protein component of caveolae membrane coats.
Cell
68:673-682[CrossRef][Medline].
|
| 55.
|
Sargiacomo, M.,
M. Sudol,
Z. L. Tang, and M. P. Lisanti.
1993.
Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells.
J. Cell Biol.
122:789-807[Abstract/Free Full Text].
|
| 56.
|
Scherer, P. E.,
R. Y. Lewis,
D. Volonte,
J. A. Engelman,
F. Galbiati,
J. Couet,
D. S. Kohtz,
E. van Donselaar,
P. Peters, and M. P. Lisanti.
1997.
Cell-type and tissue-specific expression of caveolin-2. Caveolin 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo.
J. Biol. Chem.
272:29337-29346[Abstract/Free Full Text].
|
| 57.
|
Scherer, P. E,
M. P. Lisanti,
G. Baldini,
M. Sargiacomo,
C. C. Mastick, and H. F. Lodish.
1994.
Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles.
J. Cell Biol.
127:1233-1243[Abstract/Free Full Text].
|
| 58.
|
Schlegel, A.,
D. Volonte, and J. A. Engelmann.
1999.
Crowded little caves: structure and function of caveolae.
Cell. Signal.
10:457-463.
|
| 59.
|
Shaul, P. W., and R. G. Anderson.
1998.
Role of plasmalemmal caveolae in signal transduction.
Am. J. Physiol.
275:L843-L851[Abstract/Free Full Text].
|
| 60.
|
Smart, E. J.,
G. A. Graf,
M. A. McNiven,
W. C. Sessa,
J. A. Engelman,
P. E. Scherer,
T. Okamoto, and M. P. Lisanti.
1999.
Caveolins, liquid-ordered domains, and signal transduction.
Mol. Cell. Biol.
19:7289-7304[Free Full Text].
|
| 61.
|
Song, K. S.,
S. Li,
T. Okamoto,
L. Quilliam,
M. Sargiacomo, and M. P. Lisanti.
1996.
Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent free purification of caveolae membranes.
J. Biol. Chem.
271:9690-9697[Abstract/Free Full Text].
|
| 62.
|
Sun, X. J.,
S. Pons,
T. Asano,
M. G. Myers,
E. Glasheen, and M. F. White.
1996.
The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation.
J. Biol. Chem.
271:10583-10587[Abstract/Free Full Text].
|
| 63.
|
Taggert, M. J.,
P. Leavis,
O. Feron, and K. G. Morgan.
2000.
Inhibition of PKC and rhoA translocation in differentiated smooth muscle by a caveolin scaffolding domain peptide.
Exp. Cell Res.
258:72-81[CrossRef][Medline].
|
Molecular and Cellular Biology, July 2001, p. 4553-4567, Vol. 21, No. 14
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.14.4553-4567.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Muller, G., Wied, S., Walz, N., Jung, C.
(2008). Translocation of Glycosylphosphatidylinositol-Anchored Proteins from Plasma Membrane Microdomains to Lipid Droplets in Rat Adipocytes Is Induced by Palmitate, H2O2, and the Sulfonylurea Drug Glimepiride. Mol. Pharmacol.
73: 1513-1529
[Abstract]
[Full Text]
-
Krebs, B., Kohlmannsperger, V., Nolting, S., Schmalzbauer, R., Kretzschmar, H. A.
(2006). A Method to Perform Western Blots of Microscopic Areas of Histological Sections. J. Histochem. Cytochem.
54: 559-565
[Abstract]
[Full Text]
-
Chen, G., Liu, P., Pattar, G. R., Tackett, L., Bhonagiri, P., Strawbridge, A. B., Elmendorf, J. S.
(2006). Chromium Activates Glucose Transporter 4 Trafficking and Enhances Insulin-Stimulated Glucose Transport in 3T3-L1 Adipocytes via a Cholesterol-Dependent Mechanism. Mol. Endocrinol.
20: 857-870
[Abstract]
[Full Text]
-
Liu, J., DeYoung, S. M., Zhang, M., Dold, L. H., Saltiel, A. R.
(2005). The Stomatin/Prohibitin/Flotillin/HflK/C Domain of Flotillin-1 Contains Distinct Sequences That Direct Plasma Membrane Localization and Protein Interactions in 3T3-L1 Adipocytes. J. Biol. Chem.
280: 16125-16134
[Abstract]
[Full Text]
-
Kabayama, K., Sato, T., Kitamura, F., Uemura, S., Kang, B. W., Igarashi, Y., Inokuchi, J.-i.
(2005). TNF{alpha}-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3. Glycobiology
15: 21-29
[Abstract]
[Full Text]
-
Uhles, S., Moede, T., Leibiger, B., Berggren, P.-O., Leibiger, I. B.
(2003). Isoform-specific insulin receptor signaling involves different plasma membrane domains. JCB
163: 1327-1337
[Abstract]
[Full Text]
-
Cohen, A. W., Combs, T. P., Scherer, P. E., Lisanti, M. P.
(2003). Role of caveolin and caveolae in insulin signaling and diabetes. Am. J. Physiol. Endocrinol. Metab.
285: E1151-E1160
[Abstract]
[Full Text]
-
Biedi, C., Panetta, D., Segat, D., Cordera, R., Maggi, D.
(2003). Specificity of Insulin-Like Growth Factor I and Insulin on Shc Phosphorylation and Grb2 Recruitment in Caveolae. Endocrinology
144: 5497-5503
[Abstract]
[Full Text]
-
Kwon, Y.-K., Jang, H.-J., Kole, S., He, H.-J., Bernier, M.
(2003). Role of the pleckstrin homology domain of PLC{gamma}1 in its interaction with the insulin receptor. JCB
163: 375-384
[Abstract]
[Full Text]
-
Skaletz-Rorowski, A., Lutchman, M., Kureishi, Y., Lefer, D. J., Faust, J. R., Walsh, K.
(2003). HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells. Cardiovasc Res
57: 253-264
[Abstract]
[Full Text]
-
Liu, P., Rudick, M., Anderson, R. G. W.
(2002). Multiple Functions of Caveolin-1. J. Biol. Chem.
277: 41295-41298
[Full Text]
-
Nelson, B. A., Robinson, K. A., Buse, M. G.
(2002). Insulin Acutely Regulates Munc18-c Subcellular Trafficking. ALTERED RESPONSE IN INSULIN-RESISTANT 3T3-L1 ADIPOCYTES. J. Biol. Chem.
277: 3809-3812
[Abstract]
[Full Text]
-
Bickel, P. E.
(2002). Lipid rafts and insulin signaling. Am. J. Physiol. Endocrinol. Metab.
282: E1-E10
[Abstract]
[Full Text]
-
Razani, B., Combs, T. P., Wang, X. B., Frank, P. G., Park, D. S., Russell, R. G., Li, M., Tang, B., Jelicks, L. A., Scherer, P. E., Lisanti, M. P.
(2002). Caveolin-1-deficient Mice Are Lean, Resistant to Diet-induced Obesity, and Show Hypertriglyceridemia with Adipocyte Abnormalities. J. Biol. Chem.
277: 8635-8647
[Abstract]
[Full Text]